Company presentations

JP Morgan Conference - Investor Presentation

January 2026 - available here

$205m licensing agreement with Nxera In Japan and APAC countries

January 2026 Interview with Andreas Missy, EVP Corporate Planning & Business Development - available here

Jefferies Conference - Investor Presentation

November 2025 - available here

GUARDIAN Data

Interview with Dr. Shabir Hasham, Chief Medical Officer of Santhera Pharmaceuticals - available here

Half-Year Results Presentation

September 2025 Presentation Slide deck - available here

September 2025 Presentation Video available here

Analyst Meeting - 2024 Annual Results

April 29, 2025